TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 86 filers reported holding TRICIDA INC in Q4 2021. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $21,000 | +320.0% | 1,987 | +289.6% | 0.00% | – |
| Q2 2022 | $5,000 | +25.0% | 510 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | 0.0% | 510 | +24.1% | 0.00% | – |
| Q4 2021 | $4,000 | +100.0% | 411 | +14.8% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 358 | -45.6% | 0.00% | – |
| Q1 2021 | $3,000 | -57.1% | 658 | -34.6% | 0.00% | – |
| Q4 2020 | $7,000 | +600.0% | 1,006 | +1030.3% | 0.00% | – |
| Q3 2020 | $1,000 | – | 89 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
| Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
| Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
| Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
| Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
| Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
| Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
| H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
| Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |